Nonetheless mPowerF showed a trend for being highest in the premenopausal women at rest, during MVC and in terms of relative decrement from rest to MVC in the DF (see Table 4 ).
← all excerpts
A prolonged hiatus in postmenopausal HRT, does not nullify the therapy's positive impact on ageing related sarcopenia.
1
—
—